Publicaciones en colaboración con investigadores/as de University of Padua (18)

2024

  1. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

2023

  1. Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

    Rheumatology (Oxford, England), Vol. 62, Núm. 4, pp. 1559-1567

2021

  1. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

    Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 213-222

  2. The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort

    Swiss medical weekly, Vol. 151, pp. w20528

2020

  1. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

    Arthritis research & therapy, Vol. 22, Núm. 1, pp. 257

  2. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

    Autoimmunity Reviews, Vol. 19, Núm. 2

  3. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

    Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694

2019

  1. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis

    Arthritis and Rheumatology, Vol. 71, Núm. 9, pp. 1553-1570

  2. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  3. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

2018

  1. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

    Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834

2017

  1. Update of EULAR recommendations for the treatment of systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339

2016

  1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 163-169

  2. Digital ulcers predict a worse disease course in patients with systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 4, pp. 681-686

2015

  1. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 6, pp. 1124-1131

2010

  1. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1809-1815

  2. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1488-1501

2009

  1. EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 5, pp. 620-628